Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?
Read More 5 minute read Pharma Industry News HER3-DXd shows promise in treating brain metastases: Inside the TUXEDO-3 trial results from ASCO 2025 HER3-DXd from Daiichi Sankyo and Merck shows intracranial activity in CNS cancers, as TUXEDO-3 results presented at ASCO 2025 spark major oncology interest. byPallavi MadhirajuMay 31, 2025